Title: 
Official Title: To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Remote Opioid Monitoring Act of 2025.

Section 2:
2.Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids (a)In generalNot later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate a report on the use of remote monitoring with respect to individuals who are prescribed opioids. 
(b)ReportThe report described in subsection (a) shall include— (1)an assessment of scientific evidence related to the efficacy, individual outcomes, and potential cost savings associated with remote monitoring for individuals who are prescribed opioids compared to such individuals who are not so monitored; 
(2)an assessment of the current prevalence of remote monitoring for individuals who are prescribed opioids, including the use of such monitoring for such individuals in other countries; and (3)recommendations to improve availability, access, and coverage for remote monitoring for individuals who are prescribed opioids, including through changes to Federal health care programs (as defined in section 1128B of the Social Security Act (42 U.S.C. 1320a–7b)) and, if determined appropriate by the Comptroller General, an identification of cohorts of individuals who stand to benefit the most from remote monitoring when prescribed opioids.


================================================================================

Raw Text:
119 HR 2404 IH: Remote Opioid Monitoring Act of 2025
U.S. House of Representatives
2025-03-27
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 2404IN THE HOUSE OF REPRESENTATIVESMarch 27, 2025Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo provide for a study on the effects of remote monitoring on individuals who are prescribed opioids. 
1.Short titleThis Act may be cited as the Remote Opioid Monitoring Act of 2025. 2.Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids (a)In generalNot later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate a report on the use of remote monitoring with respect to individuals who are prescribed opioids. 
(b)ReportThe report described in subsection (a) shall include— (1)an assessment of scientific evidence related to the efficacy, individual outcomes, and potential cost savings associated with remote monitoring for individuals who are prescribed opioids compared to such individuals who are not so monitored; 
(2)an assessment of the current prevalence of remote monitoring for individuals who are prescribed opioids, including the use of such monitoring for such individuals in other countries; and (3)recommendations to improve availability, access, and coverage for remote monitoring for individuals who are prescribed opioids, including through changes to Federal health care programs (as defined in section 1128B of the Social Security Act (42 U.S.C. 1320a–7b)) and, if determined appropriate by the Comptroller General, an identification of cohorts of individuals who stand to benefit the most from remote monitoring when prescribed opioids.